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Abstract: In order to assess the progression of carotid-artery disease in type 2 diabetic cohort 
(n=207 patients), the dynamic change in carotid intima-media thickness (CIMT) and the occur-
rence of plaques were followed for a period of 31.35±10.59 months. The mean CIMT at the 
beginning of the study was 0.9178±0.1447 mm, with a maximal value of 1.1210±0.2366 mm. 
The maximal value of CIMT changed by 0.07 mm/year. Progression of CIMT was noted in 
86.8% and its regression in 7.8% of patients. The occurrence of carotid plaques was detected 
in 41.8% of patients. Multiple regression analysis revealed the maximal value of CIMT to be 
associated with diastolic blood pressure, despite mean CIMT being predicted by body mass 
index. The presence of peripheral arterial disease and hypo-high-density lipoproteinemia were 
found to be predictors for the occurrence of carotid plaques. Our data have clinical implications 
in predicting risk factors for the progression of carotid-artery disease in type 2 diabetic patients 
for their appropriate management.
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Introduction
Diabetes has been defined as an independent factor for the presence of high-grade 
carotid-artery stenosis in the general population.1 Type 2 diabetes (T2D) poses a 
 substantial risk factor for the progression of atherosclerosis, measured by rise in 
carotid intima-media thickness (CIMT), expressed in length unit per patient in 
1 year, and  compared with the occurrence of plaques on the internal carotid artery 
in 1–2 years.2,3
There is a clear correlation among arterial hypertension, hypercholesterolemia, 
and inflammatory markers (c-reactive protein and serum amyloid concentration) as 
predictors of carotid atherosclerosis in patients with diabetes.4,5 We determined the 
dynamics of progression of carotid-artery disease (CAD) in patients with T2D and 
determined factors that influence it.
Patients and methods
In this prospective study, a cohort of T2D patients (n=207) were followed for a period 
of 31.35±10.59 months for dynamic changes in CIMT and the occurrence of plaques. 
T2D was defined based on the criteria of the International Diabetes Federation.
CIMT was measured by B-mode ultrasound using a linear transducer (7.5–10 MHz) 
and was performed by a single sonographer. CIMT is presented as a mean value of 
two measurements from both sides of the common carotid arteries. CIMT is defined 
as the distance from the leading edge of the first echogenic line to the leading edge 
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of the second echogenic line on the scans, with the first line 
representing the lumen–intima interface and the second 
line representing the collagen-containing upper layer of 
the adventitia. Plaque was defined as a localized thicken-
ing lesion ($1.1 mm). Carotid stenosis greater than 60% 
was considered significant. In each longitudinal projection, 
the site with the greatest thickness (including plaques) was 
detected along the vessel from the common carotid artery to 
the internal carotid artery. Peripheral arterial disease (PAD) 
was defined as ankle-brachial index (ABI) ,0.9 or .1.3. 
The observer was blinded to patient risk factors.
Standard laboratory analyses were performed in all 
patients. Multivariate analysis was performed in order to 
assess the predictors for CIMT progression. The model was 
adjusted for age. The study was conducted in accordance 
with the Helsinki declaration. This study which was a part 
of project: Diabetic polyvascular disease, was approved by 
the scientific committee of Medical Faculty Skopje. At this 
timepoint there was no need for approval from an ethics com-
mittee. Informed consent was obtained from all patients.
Results
In the study population, a mean value of IMT =0.9178 mm 
and maximal value of CIMT =1.1210 mm, respectively, were 
obtained. The maximal value of CIMT changed by 0.07 mm 
annually (Table 1).
Progression of carotid atherosclerosis was noted in 86.8%, 
followed by a change in CIMT. In 17.8% of patients, the 
occurrence of carotid stenosis was evident, while in 41.8% of 
patients, the development of new carotid plaques was noted.
Multiple linear regression analysis was performed when 
continuous variables from Table 2 were put into this model. 
The change in CIMT showed that its maximal value was pre-
dicted by the diastolic pressure value and the change in mean 
value of CIMT by body mass index (BMI). Predictors for the 
change in CIMT values annually are shown in Table 3.
Multiple regression analysis demonstrated low high-
density lipoprotein (HDL) and the presence of PAD to be 
independent factors for the progression of atherosclerotic 
plaques (Table 4). In addition, ABI values, presence of carotid 
plaques at the beginning of the study, and the presence of 
intermittent claudication were also found to be independent 
factors.
Since postprandial glycemia was included in the multiple 
linear regression analysis in the progression of CAD, the same 
value was shown as a substantive value compared to degree 
of carotid stenosis. Raised amounts of glycated hemoglobin 
(HbA
1c
) .7% were in linear correlation with maximal change 
in CIMT (Figure 1).
In order to analyze the operator’s influence on carotid 
measurements, a homogeneity test of regression was used 
Table 1 Values of ciMT in the study population
Minimum Maximum  
value
Mean  
value
Standard 
deviation
iMT 0.60 1.1210 0.9178 0.1447
ΔiMTmax/year -0.10 0.60 0.0627 0.0732
ΔiMTmean/year -0.50 0.57 0.0259 0.0802
Abbreviations: ciMT, carotid intima-media thickness; iMT, intima-media thickness; 
ΔiMTmax, change in maximal value of iMT; ΔiMTmean, change in mean value of iMT.
Table 2 continuous variables in the study population
Variables Mean  
value
Standard 
deviation
systolic pressure (mmHg) 143.9 19.6
Diastolic pressure (mmHg) 86.1 9.2
Weight (kg) 82.9 13.4
Height (cm) 169.4 7.5
Waist 96.9 8.0
BMi (kg/m2) 28.7 4.0
glycemia (mmol/l) 8.5 2.4
Total cholesterol (mmol/l) 5.4 1.4
HDl cholesterol (mmol/l) 1.0 0.4
non-HDl cholesterol (mmol/l) 4.3 1.4
lDl cholesterol (mmol/l) 3.3 0.9
Triglycerides (mmol/l) 2.0 1.0
Abbreviations: BMi, body mass index; HDl, high-density lipoprotein; lDl, low-
density lipoprotein.
Table 3 Predictors of ciMT
Model B SD β t Significance
ΔIMTmean
constant 0.765 0.150 5.096 0.000
Plaques 1.080 0.097 0.845 11.100 0.000
Physical inactivity 9.487-2 0.030 0.244 3.183 0.003
BMi 1.047-2 0.004 0.220 2.885 0.006
ΔIMTmax
constant -0.584 0.371 -1.575 0.123
Diastolic pressure 9.054-3 0.004 0.309 2.078 0.044
ΔIMTmean/year
constant -0.121 0.057 -2.127 0.040
carotid stenosis, % 0.294 0.074 0.506 3.972 0.000
,HDl -7.807-2 0.027 -349 -2.876 0.007
cVD 6.526-2 0.026 0.300 2.480 0.018
Retinopathy -8.835-2 0.043 -0.263 -2.072 0.045
ΔIMTmax/year
constant -0.487 0.121 -4.031 0.000
BMi 2.035-2 0.004 0.898 4.592 0.000
Obesity -0.146 0.038 -0.791 -3.832 0.000
PaD -0.106 0.036 -0.400 -2.925 0.006
claudication 6.924-2 0.025 0.353 2.797 0.008
Abbreviations: ciMT, carotid intima-media thickness; ΔiMTmax, change in maximal 
value of iMT; ΔiMTmean, change in mean value of iMT; BMi, body mass index; HDl, 
high-density lipoprotein; cVD, cerebro vascular disease (history of); PaD, peripheral 
arterial disease; sD, standard deviation.
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when the mean and maximal values of IMT were included. 
It was clear that there was minimal influence of the operator 
on measurements (F=17.061, P=0.018).
Discussion
The progression rate of CAD in high-risk populations has been 
previously reported to be 15%–20% annually.6–8 Our results 
are comparable with previous studies – ARIC (Atherosclerosis 
Risk in Communities Cohort) and IRAS (Insulin Resistance 
Atherosclerosis Study) – with regard to progression of CIMT 
of 0.1 mm annually in the T2D population.6–8
Randomized controlled studies have shown an inverse 
correlation between HDL cholesterol and CIMT value and 
its progression in the population with high cardiovascular 
risk and those with T2D.9 IMT, which comprises the intima 
and media, is susceptible to the influence of risk factors for 
artery disease. The enlargement of the intima is a result of the 
atherosclerotic process, and media enlargement is a response 
to vascular remodeling in high-artery-pressure conditions.10 
The SANDS study11 demonstrated that the arterial pressure 
and low-density lipoprotein (LDL) cholesterol are defined 
as independent factors with the greatest risk for progression 
of CAD. Our results show logistic regression dependency 
in plaque progression; respectively, they showed linear 
regression dependency on change in IMT mean (ΔIMT
mean
) 
from hypo-HDL-emia. Total cholesterol is an independent 
 predictor for the occurrence of carotid plaques according 
to our results. Lipid fractions, LDL cholesterol, and trig-
lycerides are important factors in the progression of carotid 
atherosclerosis in the general population and in those with 
diabetes.11 However, lipid fractions were not shown as inde-
pendent factors in the progression of carotid atherosclerosis 
in the Rotterdam study.12 This is most likely due to the high 
atherogenicity of LDL cholesterol and non-HDL cholesterol, 
even when they are within their normal range. Accomplishing 
lower LDL and non-HDL values is important in decreasing 
the progression of CAD in T2D.
Arterial hypertension is a predictor for CIMT value. 
In a meta-analysis, it was clear that for every decrease of 
5 mmHg in arterial pressure, regression of IMT of 0.01 mm/
year resulted.13
Age, male sex, smoking, and BMI are the best inde-
pendent factors in carotid-atherosclerosis progression.14,15 
Accordingly, our data demonstrate that BMI is a predictor for 
progression of IMT values (ΔIMT
mean
 and ΔIMT
max
) annually. 
The long prediabetic phase and late diagnosis of diabetes are 
independent factors in the progression of CIMT;16 however, 
in our study this was not evident.
PAD occurrence and ABI value have been shown as pre-
dictors in CAD progression, which is demonstrated in our 
results. The relationship of ABI with CAD defines not only 
PAD but the presence of diabetic polyvascular disease.17
We also examined the influence of glycemic control on 
the progression of carotid stenosis. The obtained glycemia 
values and IMT were in log-linear correlation. The degree of 
carotid stenosis was correlated with the glycemic value.
The correlation of vascular disease in diabetic patients 
with glycemic control measured by HbA
1c
 was shown in 
Selvin et al’s meta-analysis.18 Postprandial glycemia has been 
shown to be a powerful predictor against HbA
1c
 compared 
to the correlation with diabetic vascular disease.19 In the 
Table 4 Predictors for plaque progression
B SE Wald df Significance Exp(B) 95% CI Exp(B)
Lower Upper
Plaque progression
PaD 1.435 0.470 9.321 1 0.002 1.238 1.095 1.598
,HDl -0.770 0.342 5.085 1 0.024 1.463 1.237 1.904
Plaque 0.950 0.407 5.457 1 0.019 2.586 1.165 5.741
Plaques, bilateral 2.380 0.445 28.621 1 0.000 10.802 4.517 25.830
constant -1.997 0.482 17.152 1 0.000 0.136
Abbreviations: SE, standard error; CI, confidence interval; df, degrees of freedom; PaD, peripheral arterial disease; HDl, high-density lipoprotein.
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Figure 1 Relationship of glycemia to ciMT.
Abbreviations: ciMT, carotid intima-media thickness; gi, glycemia.
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DECODE study, postprandial glycemia is an independent 
predictor for CAD and mortality in patients with T2D.20 Our 
results demonstrate the correlation of carotid atherosclerosis 
with fasting glycemia.
In our study, bias might have been present because of 
the selected values of CIMT through which the progression 
of atherosclerosis is defined. For this reason, a multiple 
linear regression analysis for continuous variables of CIMT 
was used.
Progression of the carotid plaque due to multivariate 
regression analysis is predicted with the former presence of 
plaques, low HDL cholesterol and presence of PAD, ABI 
value, age, systolic blood pressure, and total cholesterol. 
Change in CIMT value is predicted with diastolic blood pres-
sure and BMI according to linear regression analysis.
These results are also meaningful when making compara-
tive analysis of certain risk factors in the progression of vas-
cular disease in certain localizations in T2D. Hyperglycemia 
is a crucial factor in the development of PAD in diabetes, and 
arterial hypertension and low HDL cholesterol for the devel-
opment of CAD in diabetes. This spectrum of significance on 
certain risk factors was supported with our results.
Conclusion
Our results indicate that the dynamics of CIMT
max
 were deter-
mined with diastolic blood pressure, despite CIMT
mean
 being 
predicted by BMI. Presence of PAD and hypo-HDL-emia 
were found to be predictors for the occurrence of carotid 
plaques. These results have clinical implications in finding 
the risk factors for the progression of CAD in T2D patients 
for appropriate clinical management.
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